ECDC rapid risk assessment outlines actions to reduce the spread of the mcr-1 gene

June 17, 2016, European Centre for Disease Prevention and Control (ECDC)
The recently recognized global distribution of the mcr-1 gene poses a substantial public health risk to the EU/EEA. The gene is widespread in several continents and has been detected in bacteria isolated from multiple different sources such as food-producing animals, food, the environment and humans. Credit: Skov RL, Monnet DL. Plasmid-mediated colisting resistance (mcr-1 gene): three months later, the story unfolds. Eurosurveillance, 2016;21(9). Updated with the latest available data on 2 June 2016 by ECDC.

The recently recognised global distribution of the mcr-1 gene poses a substantial public health risk to the EU/EEA. The gene is widespread in several continents and has been detected in bacteria isolated from multiple different sources such as food-producing animals, food, the environment and humans.

This new mechanism of to colistin is of exceptional concern because it further limits treatment options in patients with infections caused by multidrug-resistant (MDR) Gram-negative bacteria, and also because it is a highly mobile type of drug resistance (the gene is on a plasmid) that can spread more easily between bacteria.

MDR Gram-negative bacteria, including carbapenem-resistant Enterobacteriaceae strains that acquire the mcr-1 gene, remain susceptible to only a few antimicrobial agents, which means that infections caused by these strains are very difficult to treat and result in excess mortality. As the development of new antimicrobials is unlikely to provide a solution anytime soon, it is crucial to take measures to control the spread of mcr-1 and thus protect the activity of colistin.

Although there are still major information gaps, relating to the current prevalence of colistin resistance in human clinical isolates in the EU/EEA, as well as to the historical and current prevalence of colistin resistance due to the mcr-1 gene, the issue of further spread of mcr-1 needs to be taken seriously and be carefully monitored by EU/EEA countries.

Andrea Ammon, ECDC Acting Director, said: "the spread of the mcr-1 gene represents another step towards pandrug resistance and infections that would be very difficult, if not impossible, to treat. Further spread would increase the morbidity and mortality in patients undergoing advanced medical procedures, thus having a profound effect on the practice of medicine."

In its rapid risk assessment, ECDC outlines a number of actions that need to be considered to reduce identified risks of mcr-1 spread. These include improved laboratory methods for colistin resistance testing and mcr-1 detection, improved surveillance, options for appropriate clinical management, and actions to prevent transmission in healthcare settings as well as in the community.

Explore further: First discovery in United States of colistin resistance in a human E. coli infection

Related Stories

First discovery in United States of colistin resistance in a human E. coli infection

May 26, 2016
The Multidrug Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR) characterized a transferrable gene for colistin resistance in the United States that may herald ...

US to establish lab network for combating 'superbugs'

June 1, 2016
US authorities said Tuesday they are establishing a network of labs that can respond quickly to antibiotic-resistant "superbugs," following America's first human case of a dangerous strain of E. coli.

New gene that makes common bacteria resistant to last-line antibiotic found in animals and patients in China

November 19, 2015
A new gene (mcr-1) that enables bacteria to be highly resistant to polymyxins, the last line of antibiotic defence we have left, is widespread in Enterobacteriaceae taken from pigs and patients in south China, including strains ...

What you need to know about E. coli

January 8, 2016
A new drug-resistant superbug gene has been discovered in meat sold in Ontario.

New front opens in war on superbugs: experts

April 11, 2016
A newly-discovered antibiotic-resistant gene is threatening to open a new front in the war against superbugs by rendering a last-resort drug impotent, experts warn.

New technology traces resistance gene quickly

December 8, 2015
A new resistance gene has been found in coli bacteria among pigs, broiler meat and humans in China. Bacteria with the same resistance gene have now also been found in Denmark, according to a new Danish study. The National ...

Recommended for you

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

Infectivity of different HIV-1 strains may depend on which cell receptors they target

December 6, 2018
Distinct HIV-1 strains may differ in the nature of the CCR5 molecules to which they bind, affecting which cells they can infect and their ability to enter cells, according to a study published December 6 in the open-access ...

Protecting cell powerhouse paves way to better treatment of acute kidney injury

December 6, 2018
For the first time, scientists have described the body's natural mechanism for temporarily protecting the powerhouses of kidney cells when injury or disease means they aren't getting enough blood or oxygen.

New study uncovers why Rift Valley fever is catastrophic to developing fetuses

December 5, 2018
Like Zika, infection with Rift Valley fever virus can go unnoticed during pregnancy, all the while doing irreparable—often lethal—harm to the fetus. The results of a new study, led by researchers at the University of ...

Study highlights potential role of bioaerosol sampling to address airborne biological threats

December 5, 2018
As a leading global city with a high population density, Singapore is vulnerable to the introduction of biological threats. Initiating an early emergency response to such threats calls for the rapid identification of the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.